Pediatrix Medical Group, Inc. (NYSE:MD) Given Consensus Recommendation of "Hold" by Analysts

Key Points

• Consensus "Hold": Seven analysts give Pediatrix a consensus Hold (five holds, one buy, one strong buy) with an average 12‑month price target of $19.80, and several firms have recently trimmed targets (Truist to $21, UBS to $22, Deutsche Bank to $19).
• Recent quarter showed EPS $0.50, missing estimates by $0.03 while revenue of $493.8M beat expectations but declined 1.7% year‑over‑year; analysts project ~1.38 EPS for the current year.
• Shares trade around $21.19, reflecting a market cap of $1.76B and a P/E of 10.92, with institutional investors holding about 97.7% of the stock.

Shares of Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) have received a consensus recommendation of "Hold" from the seven brokerages that are covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $19.80.

Several analysts have weighed in on the company. Truist Financial cut their price objective on Pediatrix Medical Group from $24.00 to $21.00 and set a "hold" rating on the stock in a research report on Thursday, February 19th. Deutsche Bank Aktiengesellschaft set a $19.00 target price on Pediatrix Medical Group in a research note on Friday, February 20th. Zacks Research lowered Pediatrix Medical Group from a "strong-buy" rating to a "hold" rating in a research report on Friday, January 23rd. UBS Group dropped their price objective on shares of Pediatrix Medical Group from $23.00 to $22.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 24th. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Pediatrix Medical Group in a report on Friday, March 27th.

Pediatrix Medical Group Trading Up 2.4%

NYSE:MD opened at $21.19 on Friday. The company has a 50-day moving average price of $20.47 and a 200-day moving average price of $20.35. Pediatrix Medical Group has a 12 month low of $11.84 and a 12 month high of $24.99. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.66. The stock has a market cap of $1.76 billion, a price-to-earnings ratio of 10.92 and a beta of 0.72.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings results on Thursday, February 19th. The company reported $0.50 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.53 by ($0.03). Pediatrix Medical Group had a net margin of 8.64% and a return on equity of 19.59%. The company had revenue of $493.77 million for the quarter, compared to analysts' expectations of $486.23 million. During the same quarter in the prior year, the firm earned $0.51 EPS. Pediatrix Medical Group's quarterly revenue was down 1.7% compared to the same quarter last year. Equities analysts predict that Pediatrix Medical Group will post 1.38 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Global Retirement Partners LLC raised its stake in Pediatrix Medical Group by 68,250.0% during the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company's stock valued at $29,000 after buying an additional 1,365 shares during the last quarter. Transamerica Financial Advisors LLC bought a new position in shares of Pediatrix Medical Group during the fourth quarter valued at $30,000. Eurizon Capital SGR S.p.A. purchased a new position in shares of Pediatrix Medical Group in the 4th quarter worth about $33,000. Blue Trust Inc. purchased a new position in shares of Pediatrix Medical Group in the 4th quarter worth about $37,000. Finally, TD Private Client Wealth LLC bought a new position in Pediatrix Medical Group in the 4th quarter worth about $39,000. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc NYSE: MD is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.